[{"Assets_0_Q3_USD":273132000.0,"CommonStockSharesOutstanding_0_Q3_shares":14662000.0,"EarningsPerShareBasic_1_Q3_USD":0.47,"EarningsPerShareBasic_3_Q3_USD":1.63,"EarningsPerShareDiluted_1_Q3_USD":0.46,"EarningsPerShareDiluted_3_Q3_USD":1.58,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":33831000.0,"NetIncomeLoss_3_Q3_USD":23749000.0,"NetIncomeLoss_1_Q3_USD":6887000.0,"StockholdersEquity_0_Q3_USD":253289000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":15115000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":15065000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":14579000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":14572000.0,"Ticker":"ANIK","CIK":"898437","name":"ANIKA THERAPEUTICS, INC.","OfficialName":"Anika Therapeutics Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"337949354.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20171027"}]